Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL735815 | 0.97 | KIF11 (0.36) | KIF11CYP2D6 | |
| Hydrochloric Acid SCHEMBL20637046 | 0.97 | KIF11 (0.36) | KIF11CYP2D6 | |
| SCHEMBL15256844 | 0.89 | KIF11 (0.37) | KIF11 | |
| SCHEMBL20644946 | 0.84 | KIF11 (0.30) | KIF11 | |
| SCHEMBL18217824 | 0.84 | CA12 (0.35) | KIF11 | |
| SCHEMBL9886710 | 0.83 | — | — | |
| SCHEMBL10041227 | 0.81 | ODC1 (0.43) | — | |
| SCHEMBL20644947 | 0.81 | ALDH1A1 (0.32) | — | |
| SCHEMBL16508698 | 0.81 | — | — | |
| SCHEMBL131286 | 0.80 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 227 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3389641-B1 | PROTEIN NANOCAPSULES WITH DETACHABLE ZWITTERIONIC COATING FOR PROTEIN DELIVERY | UNIV CALIFORNIA (US) | 2026-04-08 | — | — | EP | claimed |
| US-20250377336-A1 | COATING INNER SURFACES OF ENCLOSED ARTICLES | UNIV TASMANIA (AU) | 2025-12-11 | — | — | US | claimed |
| EP-4540292-A1 | COATING INNER SURFACES OF ENCLOSED ARTICLES | University Of Tasmania (AU) | 2025-04-23 | — | — | EP | claimed |
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | INSTITUTE OF PROCESS ENGINEERING , CHINESE ACADEMY OF SCIENCES (CN) | 2025-04-10 | — | — | US | claimed |
| WO-2024183010-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | 中国科学院过程工程研究所 | 2024-09-12 | — | — | WO | claimed |
| WO-2023245238-A1 | COATING INNER SURFACES OF ENCLOSED ARTICLES | UNIVERSITY OF TASMANIA (AU) | 2023-12-28 | — | — | WO | claimed |
| WO-2023144709-A1 | PREPARATION AND APPLICATION OF POLYIMIDE INTERMEDIATES FOR ANTI-CORROSION COATING ON METAL SURFACES | TATA STEEL LIMITED (IN) | 2023-08-03 | — | — | WO | claimed |
| US-11491711-B2 | Method of making 3D printed objects using two distinct light sources | PHOTOCENTRIC LIMITED (GB) | 2022-11-08 | — | — | US | claimed |
| EP-3762438-A1 | BIOCIDAL COATING MATERIAL AND ASSOCIATED PRODUCTION PROCESS | El Kudsi, Karim (DE) | 2021-01-13 | — | — | EP | claimed |
| EP-3717023-A1 | COMPOSITIONS AND METHODS FOR DRUG DELIVERY | Vivibaba, Inc (US) | 2020-10-07 | — | — | EP | claimed |
| US-20180161441-A1 | STAPLED ACID-SENSITIVE ENDOSOME DISRUPTING ALGINATES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION | 2018-06-14 | — | — | US | claimed |
| EP-3320002-A1 | POLYMERIZATION SYSTEM USING DOUBLE CLICK MICHAEL ADDITION AND PHOTOPOLYMERIZATION | Université de Haute Alsace (FR) | 2018-05-16 | — | — | EP | claimed |
| EP-3288520-A1 | USE OF ACTIVE AGENTS DURING CHEMICAL TREATMENTS | L'OREAL (FR) | 2018-03-07 | — | — | EP | claimed |
| WO-2017106380-A1 | PROTEIN NANOCAPSULES WITH DETACHABLE ZWITTERIONIC COATING FOR PROTEIN DELIVERY | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2017-06-22 | — | — | WO | claimed |
| WO-2017009127-A1 | POLYMERIZATION SYSTEM USING DOUBLE CLICK MICHAEL ADDITION AND PHOTOPOLYMERIZATION | UNIVERSITÉ DE HAUTE-ALSACE (FR) | 2017-01-19 | — | — | WO | claimed |
| EP-3115381-A1 | POLYMERIZATION SYSTEM USING DOUBLE CLICK MICHAEL ADDITION AND PHOTOPOLYMERIZATION | Université de Haute Alsace (FR) | 2017-01-11 | — | — | EP | claimed |
| WO-2017004071-A1 | STAPLED ACID-SENSITIVE ENDOSOME DISRUPTING ALGINATES | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2017-01-05 | — | — | WO | claimed |
| WO-2016179017-A1 | USE OF ACTIVE AGENTS DURING CHEMICAL TREATMENTS | L'OREAL (FR) | 2016-11-10 | — | — | WO | claimed |
| EP-0394318-A1 | POLYMERS AND POLYMER-PEPTIDE CONJUGATES | MEDICAL RESEARCH COUNCIL (GB) | 1990-10-31 | — | — | EP | claimed |
| WO-1989005305-A1 | POLYMERS AND POLYMER-PEPTIDE CONJUGATES | 3I RESEARCH EXPLOITATION LIMITED (GB) | 1989-06-15 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114479-A1 | TISSUE-SELECTIVE SINGLE-COMPONENT MRNA DELIVERY CARRIER AND DELIVERY SYSTEM | SLC43A1, LNPEP, TLR3 | KIF11 4378/4885CYP2D6 3956/4885 |
| US-20180161441-A1 | STAPLED ACID-SENSITIVE ENDOSOME DISRUPTING ALGINATES | ALG1, ALG8, EEA1 | KIF11 1082/4885CYP2D6 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.